Samsung Biologics Co Ltd (207940)

Seoul
Currency in KRW
1,087,000
+34,000(+3.23%)
Closed
207940 Scorecard
Full Analysis
2 analysts have revised their earnings downwards for the upcoming period
Fair Value
Day's Range
1,063,0001,092,000
52 wk Range
721,0001,113,000
Key Statistics
Edit
Bid/Ask
1,087,000.00 / 1,088,000.00
Prev. Close
1,053,000
Open
1,072,000
Day's Range
1,063,000-1,092,000
52 wk Range
721,000-1,113,000
Volume
106.6K
Average Volume (3m)
74.27K
1-Year Change
38.47%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
207940 Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
1,240,120
Upside
+14.09%
Members' Sentiments
Bearish
Bullish
ProTips
RSI suggests the stock is in overbought territory
Show more

Samsung Biologics Co Ltd Company Profile

Samsung Biologics Co.,Ltd. engages in the contract development and manufacturing organization (CDMO) business for biopharmaceuticals products in South Korea, Europe, the United States, and internationally. The company operates in two segments, CDMO, and Biopharmaceutical Development and Commercialization. Its development services include discovery, cell line development, process development, and clinical manufacturing. The company also offers aseptic filling, lyophilization, finishing, storage and shipping, and support services; and quality assurance and control, as well as biosafety and analytical testing services. In addition, it engages in the research and commercialization of biosimilar drugs; development and manufacture of antibody-drug conjugates; and manufactures mammalian and mRNA products. The company was founded in 2011 and is headquartered in Incheon, South Korea.

Employees
4744

Compare 207940 to Peers and Sector

Metrics to compare
207940
Peers
Sector
Relationship
P/E Ratio
73.5x11.7x−0.6x
PEG Ratio
5.960.050.00
Price/Book
7.3x1.8x2.6x
Price / LTM Sales
17.7x2.5x3.1x
Upside (Analyst Target)
17.9%28.2%51.3%
Fair Value Upside
Unlock−4.4%7.3%Unlock

Analyst Ratings

23 Buy
2 Hold
0 Sell
Ratings:
25 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 1,240,120
(+14.09% Upside)

Earnings

Latest Release
Jan 22, 2025
EPS / Forecast
3,960.73 / 3,687.17
Revenue / Forecast
1.2564T / 1.235T
EPS Revisions
Last 90 days

FAQ

What Is the Samsung Biologics (207940) Stock Price Today?

The Samsung Biologics stock price today is 1,087,000.00

What Stock Exchange Does Samsung Biologics Trade On?

Samsung Biologics is listed and trades on the Seoul stock exchange.

What Is the Stock Symbol for Samsung Biologics?

The stock symbol for Samsung Biologics is "207940."

What Is the Samsung Biologics Market Cap?

As of today, Samsung Biologics market cap is 77.37T.

What is Samsung Biologics Earnings Per Share?

The Samsung Biologics EPS is 14,787.79.

What Is the Next Samsung Biologics Earnings Date?

Samsung Biologics will release its next earnings report on 22 Apr 2025.

From a Technical Analysis Perspective, Is 207940 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.